Exchange Traded Concepts LLC acquired a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 28,388 shares of the company's stock, valued at approximately $507,000. Exchange Traded Concepts LLC owned approximately 0.08% of Grail as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. FNY Investment Advisers LLC acquired a new stake in Grail in the 4th quarter worth approximately $26,000. B & T Capital Management DBA Alpha Capital Management acquired a new stake in shares of Grail during the fourth quarter worth $387,000. A. D. Beadell Investment Counsel Inc. acquired a new stake in shares of Grail during the fourth quarter worth $430,000. Wesbanco Bank Inc. purchased a new stake in shares of Grail during the fourth quarter valued at $523,000. Finally, 180 Wealth Advisors LLC acquired a new position in shares of Grail in the 4th quarter valued at $1,681,000.
Grail Stock Performance
Shares of NASDAQ GRAL traded down $1.43 during trading on Monday, reaching $28.86. 1,145,987 shares of the company traded hands, compared to its average volume of 1,090,046. The firm's fifty day simple moving average is $20.34 and its 200 day simple moving average is $16.64. Grail, Inc. has a 12-month low of $12.33 and a 12-month high of $32.65.
Grail (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($3.94) earnings per share for the quarter. The company had revenue of $28.65 million during the quarter. On average, equities analysts forecast that Grail, Inc. will post -65.16 earnings per share for the current year.
Insider Activity at Grail
In related news, CFO Aaron Freidin sold 30,452 shares of Grail stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $14.02, for a total value of $426,937.04. Following the completion of the transaction, the chief financial officer now owns 268,277 shares in the company, valued at $3,761,243.54. The trade was a 10.19 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Analyst Upgrades and Downgrades
Several analysts have weighed in on GRAL shares. Morgan Stanley initiated coverage on Grail in a research note on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 price target on the stock. Guggenheim started coverage on Grail in a research report on Thursday, October 17th. They issued a "neutral" rating on the stock. Finally, Wolfe Research started coverage on shares of Grail in a research report on Friday, November 15th. They set a "peer perform" rating for the company.
View Our Latest Research Report on Grail
Grail Profile
(
Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Recommended Stories
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
